The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
The mitochondrial p53 pathway
Open accessAbstract
p53 is one of the most mutated tumor suppressors in human cancers and as such has been intensively studied for a long time. p53 is a major orchestrator of the cellular response to a broad array of stress types by regulating apoptosis, cell cycle arrest, senescence, DNA repair and genetic stability. For a long time it was thought that these functions of p53 solely rely on its function as a transcription factor, and numerous p53 target genes have been identified [1]. In the last 8 years however, a novel transcription-independent proapoptotic function mediated by the cytoplasmic pool of p53 has been revealed. p53 participates directly in the intrinsic apoptosis pathway by interacting with the multidomain members of the Bcl-2 family to induce mitochondrial outer membrane permeabilization. Our review will discuss these studies, focusing on recent advances in the field.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Most notably, p53 can directly promote mitochondrial outer-membrane permeabilization (MOMP) to trigger apoptosis (Green and Kroemer, 2009; Vaseva and Moll, 2009).”
From p53 at a glance (2010) · cites this paper as Vaseva and Moll, 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mitochondrial membrane permeabilization in cell death
Kroemer, G., Galluzzi, L., & Brenner, C. (2007) · Physiological Reviews · doi:10.1152/physrev.00013.2006 · Cited by 3,598
Gene Silencing in Cancer in Association with Promoter Hypermethylation
Herman, J. G., & Baylin, S. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023075 · Cited by 3,422
Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA
Andrews, R. M., Kubacka, I., Chinnery, P. F., Lightowlers, R. N., Turnbull, D. M., & Howell, N. (1999) · Nature Genetics · doi:10.1038/13779 · Cited by 3,337
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473
Direct Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and Apoptosis
Chipuk, J. E., Kuwana, T., Bouchier-Hayes, L., Droin, N. M., Newmeyer, D. D., Schuler, M., & Green, D. R. (2004) · Science · doi:10.1126/science.1092734 · Cited by 2,108 · cited 3×
“Indeed, purified p53 is able to displace tBid and Bax from inhibitory complexes formed with Bcl-xL in vitro [13].”
InfluentialRestoration of p53 function leads to tumour regression in vivo
Ventura, A., Kirsch, D. G., McLaughlin, M. E., Tuveson, D. A., Grimm, J., Lintault, L., Newman, J., Reczek, E. E., Weissleder, R., & Jacks, T. (2007) · Nature · doi:10.1038/nature05541 · Cited by 1,820
p53 Has a Direct Apoptogenic Role at the Mitochondria
Mihara, M., Erster, S., Zaika, A., Petrenko, O., Chittenden, T., Pancoska, P., & Moll, U. M. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00050-9 · Cited by 1,777
Self-citationRecognition of the polyubiquitin proteolytic signal
Thrower, J. S. (2000) · The EMBO Journal · doi:10.1093/emboj/19.1.94 · Cited by 1,716
Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?
Baylin, S. B., & Ohm, J. E. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1799 · Cited by 1,639
The codon 72 polymorphic variants of p53 have markedly different apoptotic potential
Dumont, P., Leu, J. I.-J., Della Pietra, A. C., George, D. L., & Murphy, M. (2003) · Nature Genetics · doi:10.1038/ng1093 · Cited by 1,273
Death Signal-induced Localization of p53 Protein to Mitochondria
Marchenko, N. D., Zaika, A., & Moll, U. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.21.16202 · Cited by 901
Self-citationp53-Dependent apoptosis in the absence of transcriptional activation of p53-target genes
Caelles, C., Helmberg, A., & Karin, M. (1994) · Nature · doi:10.1038/370220a0 · Cited by 843
Mitochondrial p53 activates Bak and causes disruption of a Bak–Mcl1 complex
Leu, J. I.-J., Dumont, P., Hafey, M., Murphy, M. E., & George, D. L. (2004) · Nature Cell Biology · doi:10.1038/ncb1123 · Cited by 770
Modeling the Therapeutic Efficacy of p53 Restoration in Tumors
Martins, C. P., Brown-Swigart, L., & Evan, G. I. (2006) · Cell · doi:10.1016/j.cell.2006.12.007 · Cited by 600
Mitochondrial transcription factors B1 and B2 activate transcription of human mtDNA
Falkenberg, M., Gaspari, M., Rantanen, A., Trifunovic, A., Larsson, N.-G., & Gustafsson, C. M. (2002) · Nature Genetics · doi:10.1038/ng909 · Cited by 598 · cited 1×
“Major mitochondrial transcription factors are mtTFA and TFBM1 and 2, which regulate the HSP and LSP promoters [55].”
PUMA Couples the Nuclear and Cytoplasmic Proapoptotic Function of p53
Chipuk, J. E., Bouchier-Hayes, L., Kuwana, T., Newmeyer, D. D., & Green, D. R. (2005) · Science · doi:10.1126/science.1114297 · Cited by 546
Induction of apoptosis in HeLa cells by trans-activation-deficient p53.
Haupt, Y., Rowan, S., Shaulian, E., Vousden, K. H., & Oren, M. (1995) · Genes & Development · doi:10.1101/gad.9.17.2170 · Cited by 545
Transcriptional regulation by p53: one protein, many possibilities
Laptenko, O., & Prives, C. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401916 · Cited by 505
Current Status of Gendicine in China: Recombinant Human Ad-p53 Agent for Treatment of Cancers
Peng, Z. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.1016 · Cited by 436
Erster, S., Mihara, M., Kim, R. H., Petrenko, O., & Moll, U. M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.15.6728-6741.2004 · Cited by 368
Self-citationDistinct monoubiquitin signals in receptor endocytosis
Haglund, K. (2003) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2003.09.005 · Cited by 367
Small-molecule inhibitor of p53 binding to mitochondria protects mice from gamma radiation
Strom, E., Sathe, S., Komarov, P. G., Chernova, O. B., Pavlovska, I., Shyshynova, I., Bosykh, D. A., Burdelya, L. G., Macklis, R. M., Skaliter, R., et al. (2006) · Nature Chemical Biology · doi:10.1038/nchembio809 · Cited by 327
Monoubiquitylation promotes mitochondrial p53 translocation
Marchenko, N. D., Wolff, S., Erster, S., Becker, K., & Moll, U. M. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601560 · Cited by 286
Self-citationNovel role of p53 in maintaining mitochondrial genetic stability through interaction with DNA Pol γ
Achanta, G., Sasaki, R., Feng, L., Carew, J. S., Lu, W., Pelicano, H., Keating, M. J., & Huang, P. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600819 · Cited by 285
Tomita, Y., Marchenko, N., Erster, S., Nemajerova, A., Dehner, A., Klein, C., Pan, H., Kessler, H., Pancoska, P., & Moll, U. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m507611200 · Cited by 248
Self-citationp53 and Nur77/TR3 – transcription factors that directly target mitochondria for cell death induction
Moll, U. M., Marchenko, N., & Zhang, X.-K. (2006) · Oncogene · doi:10.1038/sj.onc.1209601 · Cited by 240
Self-citationKelly, K. J., Plotkin, Z., Vulgamott, S. L., & Dagher, P. C. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000040596.23073.01 · Cited by 230
Why did p53 gene therapy fail in ovarian cancer?
Zeimet, A. G., & Marth, C. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01139-2 · Cited by 199
Wolff, S., Erster, S., Palacios, G., & Moll, U. M. (2008) · Cell Research · doi:10.1038/cr.2008.62 · Cited by 186
Self-citationYoshida, Y., Izumi, H., Torigoe, T., Ishiguchi, H., Itoh, H., Kang, D., & Kohno, K. (2003) · PubMed · Cited by 175
Sansome, C., Zaika, A., Marchenko, N. D., & Moll, U. M. (2001) · FEBS Letters · doi:10.1016/s0014-5793(00)02368-1 · Cited by 174
Self-citationEndo, H., Kamada, H., Nito, C., Nishi, T., & Chan, P. H. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0897-06.2006 · Cited by 163
Signaling Through Monoubiquitination
Sigismund, S., Polo, S., & Fiore, P. P. D. (2004) · Current topics in microbiology and immunology · doi:10.1007/978-3-540-69494-6_6 · Cited by 157
Arima, Y., Nitta, M., Kuninaka, S., Zhang, D., Fujiwara, T., Taya, Y., Nakao, M., & Saya, H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410691200 · Cited by 152
Direct Regulation of Mitochondrial RNA Synthesis by Thyroid Hormone
Enríquez, J. A., Fernández‐Silva, P., Garrido-Pérez, N., López-Pérez, M. J., Martos, A. P., & Montoya, J. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.657 · Cited by 152
Roth, J. A. (2005) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.6.1.55 · Cited by 131
Apoptosis in ischemic renal injury: Roles of GTP depletion and p53
Dagher, P. C. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.761_7.x · Cited by 117
Defining the p53 DNA‐binding domain/Bcl‐xL‐binding interface using NMR
Petros, A. M., Gunasekera, A. H., Xu, N., Olejniczak, E. T., & Fesik, S. W. (2004) · FEBS Letters · doi:10.1016/s0014-5793(04)00059-6 · Cited by 111
Leu, J. I.-J., & George, D. L. (2007) · Genes & Development · doi:10.1101/gad.1567107 · Cited by 104
p53 functions in the incorporation step in DNA base excision repair in mouse liver mitochondria
de Souza-Pinto, N. C., Harris, C. C., & Bohr, V. A. (2004) · Oncogene · doi:10.1038/sj.onc.1207874 · Cited by 101
Oligomerization of BAK by p53 Utilizes Conserved Residues of the p53 DNA Binding Domain
Pietsch, E. C., Perchiniak, E. M., Canutescu, A. A., Wang, G., Dunbrack, R. L., & Murphy, M. E. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710539200 · Cited by 97
Endocrine regulation of mitochondrial activity: involvement of truncated RXRα and c‐Erb Aαl proteins
Casas, F., Daury, L., Grandemange, S., Busson, M., Seyer, P., Hatier, R., Carazo, Á., Cabello, G., & Wrutniak‐Cabello, C. (2003) · The FASEB Journal · doi:10.1096/fj.02-0732com · Cited by 94
Oncogene-dependent Regulation of Caspase Activation by p53 Protein in a Cell-free System
Ding, H., McGill, G. G., Rowan, S., Schmaltz, C., Shimamura, A., & Fisher, D. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.43.28378 · Cited by 90
Oxidative stress induces p53‐mediated apoptosis in glia: p53 transcription‐independent way to die
Bonini, P., Cicconi, S., Cardinale, A., Vitale, C., Serafino, A., Ciotti, M. T., & Marlier, L. N. J. L. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10822 · Cited by 86
The Role of Ubiquitination in the Direct Mitochondrial Death Program of p53
Marchenko, N. D., & Moll, U. M. (2007) · Cell Cycle · doi:10.4161/cc.6.14.4503 · Cited by 76
Self-citationMitochondrially Targeted p53 Has Tumor Suppressor Activities In vivo
Talos, F., Petrenko, O., Mena, P., & Moll, U. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1084 · Cited by 76
Self-citationp53 facilitates pRb cleavage in IL‐3‐deprived cells: novel pro‐apoptotic activity of p53
Gottlieb, E., & Oren, M. (1998) · The EMBO Journal · doi:10.1093/emboj/17.13.3587 · Cited by 73
Sot, B., Freund, S. M. V., & Fersht, A. R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705544200 · Cited by 65
Direct influence of the p53 tumor suppressor on mitochondrial biogenesis and function
Donahue, R. J., Razmara, M., Hoek, J. B., & Knudsen, T. B. (2001) · The FASEB Journal · doi:10.1096/fj.00-0262com · Cited by 65
Identification of a putative p53 binding sequence within the human mitochondrial genome
Heyne, K., Mannebach, S., Wuertz, E., Knaup, K. X., Mahyar-Roemer, M., & Roemer, K. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.10.099 · Cited by 61
Ibrahim, M. M., Razmara, M., Nguyen, D. N., Donahue, R. J., Wubah, J. A., & Knudsen, T. B. (1998) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(98)00066-4 · Cited by 47
Nemajerová, A., Erster, S. H., & Moll, U. M. (2004) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401526 · Cited by 44
Self-citationEndo, H., Saito, A., & Chan, P. H. (2006) · Biochemical Society Transactions · doi:10.1042/bst0341283 · Cited by 37
Mitochondrially targeted wild-type p53 suppresses growth of mutant p53 lymphomas in vivo
Palacios, G. F., & Moll, U. M. (2006) · Oncogene · doi:10.1038/sj.onc.1209641 · Cited by 32
Self-citationMitochondrially targeted wild-type p53 induces apoptosis in a solid human tumor xenograft model
Palacios, G. F., Crawford, H. C., Vaseva, A. V., & Moll, U. M. (2008) · Cell Cycle · doi:10.4161/cc.7.16.6070 · Cited by 28
Self-citationResistance of mitochondrial p53 to dominant inhibition
Heyne, K., Schmitt, K., Mueller, D., Armbruester, V., Mestres, P., & Roemer, K. (2008) · Molecular Cancer · doi:10.1186/1476-4598-7-54 · Cited by 28
Račay, P., Tatarková, Z., Drgova, A., Kaplán, P., & Dobrota, D. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9437-3 · Cited by 23
P53 Protein Is a Reliable Marker in Identification of Renal Tubular Injury
McLaren, B. K., Zhang, P. L., & Herrera, G. A. (2004) · Applied immunohistochemistry & molecular morphology · doi:10.1097/00129039-200409000-00007 · Cited by 11
Cited by
Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680
Self-citationThe first 30 years of p53: growing ever more complex.
Levine, A. J., & Oren, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2723 · Cited by 1,967
Vyas, S., Zaganjor, E., & Haigis, M. C. (2016) · Cell · doi:10.1016/j.cell.2016.07.002 · Cited by 1,735
Pistritto, G., Trisciuoglio, D., Ceci, C., Garufi, A., & D'Orazi, G. (2016) · Aging · doi:10.18632/aging.100934 · Cited by 1,658
Cellular Stress Responses: Cell Survival and Cell Death
Fulda, S., Gorman, A. M., Hori, O., & Samali, A. (2010) · International Journal of Cell Biology · doi:10.1155/2010/214074 · Cited by 1,519
Metadata
- Authors
- Vaseva, A. V., & Moll, U. M.
- Venue
- Biochimica et Biophysica Acta (BBA) - Bioenergetics
- Publisher
- Elsevier BV
- Published
- 2009-05
- Volume
- 1787
- Issue
- 5
- Pages
- 414-420
- ISSN
- 0005-2728 (ISSN-L)
- OpenAlex
- W2002936090
- Cited by
- 618
- References
- 58
- FWCI
- 11.54
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.